Upadacitinib for treating active non-radiographic axial spondyloarthritis

Equality Impact Assessment (Guidance development) (PDF 139 KB)

Final draft guidance

Final appraisal document (PDF 162 KB)

Committee papers (PDF 2.79 MB)

Committee papers Technical Briefing Document (PDF 1.08 MB)

Final scope (PDF 225 KB)

Final stakeholder list (PDF 162 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 346 KB)

Equality impact assessment (Scoping) (PDF 117 KB)

Draft scope post referral (PDF 246 KB)

Draft matrix post referral (PDF 162 KB)